Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy
NCT02151604Phase 2Completed
- Sponsor
- Oxford University Hospitals
- Start
- Apr 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in non-small cell lung cancer (NSCLC), sponsored by Oxford University Hospitals. Started Apr 2014; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02151604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151604.